Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04496362 · ClinicalTrials.gov registry record · Phase 4
Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study
A Phase 4 study of Respiratory Failure and ECMO, sponsored by Baylor Research Institute.
- Active
- Registry status
- Phase 4
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT04496362 is a Phase 4 study of Respiratory Failure and ECMO that is active but no longer recruiting, run by Baylor Research Institute. The registered enrollment target is 100 participants, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.
The verdict
NCT04496362, a Phase 4 study of Respiratory Failure and ECMO, is active but no longer recruiting, sponsored by Baylor Research Institute.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
This single-center, open-label study will evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure.
Conditions Studied
Interventions
- DRUG subcutaneous heparin anticoagulation
Study Locations (1)
Texas
- Baylor Scott & White Health research institute - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-10-10 |
| Est. Completion | 2026-06 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04496362
The ClinicalTrials.gov registry entry for NCT04496362 describes a study currently listed as active not recruiting, categorized as Phase 4. The registered enrollment target is 100 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,521-participant average among 40 other Respiratory Failure trials with a reported enrollment target (98% lower). The listed sponsor is Baylor Research Institute, which has 180 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Respiratory Failure appearing as the primary indexed condition, and to 1 intervention - of which subcutaneous heparin anticoagulation is the first listed.
NCT04496362 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT04496362 about?
NCT04496362 is a clinical study titled "Veno-venous Extracorporeal Membrane Oxygenation (VV-ECMO) Heparin Study". This single-center, open-label study will evaluate the safety and efficacy of subcutaneous heparin anticoagulation compared to the standard of care systemic intravenous anticoagulation during veno-venous extracorporeal membrane oxygenation for respiratory failure.
What is the current status of trial NCT04496362?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 100 participants. The study started on 2018-10-10. Estimated completion is 2026-06.
What conditions does trial NCT04496362 study?
This clinical trial studies the following conditions: Respiratory Failure, ECMO, Heparin.
What interventions are being tested in trial NCT04496362?
The interventions under investigation include: subcutaneous heparin anticoagulation (DRUG).
Who is sponsoring clinical trial NCT04496362?
This trial is sponsored by Baylor Research Institute, which has 180 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04496362 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Respiratory Failure
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Inhaled Nitric Oxide by Oxygen Hood in Neonates
COMPLETED · Phase 4
-
Analgesia-First Sedation in Trauma Patients
RECRUITING · NA
-
Hospital Airway Resuscitation Trial
RECRUITING · NA
-
Supraglottic Airway for Resuscitation in Preemies
RECRUITING · NA
-
The Family Perspectives Project Pilot Trial
RECRUITING · NA
-
End-Tidal Oxygen for Intubation in the Emergency Department
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.